Ascendis Pharma AS (A71) — Financial Flexibility Index
Ascendis Pharma AS (A71) has a Financial Flexibility Index of -0.01x as of March 2026. Free cash flow of €-7.72 Million (operating CF €-7.72 Million minus capex €0.00) represents 0% of total liabilities (€1.52 Billion). Check A71 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Ascendis Pharma AS Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Ascendis Pharma AS across 10 annual periods. See Ascendis Pharma AS short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Ascendis Pharma AS (2016–2025)
Year-by-year free cash flow to debt coverage for Ascendis Pharma AS. For the full company profile including market capitalisation, see market cap of Ascendis Pharma AS.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.04x | €62.38 Million | €53.90 Million | €1.47 Billion | ▲ +118.0% |
| 2024 | -0.24x | €-304.77 Million | €-306.20 Million | €1.29 Billion | ▲ +50.5% |
| 2023 | -0.48x | €-464.92 Million | €-467.36 Million | €971.28 Million | ▲ +17.8% |
| 2022 | -0.58x | €-481.21 Million | €-495.70 Million | €826.39 Million | ▲ +70.2% |
| 2021 | -1.96x | €-393.94 Million | €-417.65 Million | €201.29 Million | ▼ -9.7% |
| 2020 | -1.78x | €-251.69 Million | €-271.55 Million | €141.08 Million | ▲ +16.8% |
| 2019 | -2.14x | €-170.78 Million | €-175.94 Million | €79.62 Million | ▲ +38.7% |
| 2018 | -3.50x | €-136.15 Million | €-138.80 Million | €38.92 Million | ▲ +11.7% |
| 2017 | -3.96x | €-94.16 Million | €-95.10 Million | €23.77 Million | ▲ +10.4% |
| 2016 | -4.42x | €-59.51 Million | €-60.18 Million | €13.46 Million | — |